BE693079A - - Google Patents

Info

Publication number
BE693079A
BE693079A BE693079DA BE693079A BE 693079 A BE693079 A BE 693079A BE 693079D A BE693079D A BE 693079DA BE 693079 A BE693079 A BE 693079A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE693079A publication Critical patent/BE693079A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE693079D 1966-01-25 1967-01-24 BE693079A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52282966A 1966-01-25 1966-01-25

Publications (1)

Publication Number Publication Date
BE693079A true BE693079A (ko) 1967-07-24

Family

ID=24082557

Family Applications (1)

Application Number Title Priority Date Filing Date
BE693079D BE693079A (ko) 1966-01-25 1967-01-24

Country Status (14)

Country Link
US (1) US3459763A (ko)
AT (1) AT262997B (ko)
BE (1) BE693079A (ko)
CH (1) CH474522A (ko)
DE (1) DE1695005A1 (ko)
DK (1) DK121302B (ko)
ES (1) ES336020A1 (ko)
FR (2) FR1508888A (ko)
GB (1) GB1131191A (ko)
GR (1) GR36359B (ko)
IL (1) IL27312A (ko)
NL (1) NL6701100A (ko)
NO (1) NO117129B (ko)
SE (1) SE339475B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700685A (en) * 1970-05-15 1972-10-24 Merck & Co Inc Nitroimidazole derivatives
US3859302A (en) * 1973-02-05 1975-01-07 Monsanto Co Preparation of 2-imino-imidazole derivatives
FR2269341B1 (ko) * 1974-04-30 1978-07-28 Castaigne Sa
US4195092A (en) * 1977-12-27 1980-03-25 Eli Lilly And Company 2-(Substituted amino)-N-(3-substituted phenyl)-2-imidazoline-1-carbothioamides
EP0656210A1 (en) * 1993-11-19 1995-06-07 Takeda Chemical Industries, Ltd. Imidazole derivatives as glutaminose inhibitors
CA2181909C (en) * 1994-01-24 2008-10-07 Stephen A. Munk Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6087361A (en) * 1995-05-12 2000-07-11 Allergan Sales, Inc. Aryl-imidazolines and aryl-imidazoles useful as α-2 adrenergic agonists without cardiovascular side effects
AU2096901A (en) * 1999-12-17 2001-06-25 Procter & Gamble Company, The N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
US6596739B2 (en) 2000-03-29 2003-07-22 The Procter & Gamble Company N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
US20050054705A1 (en) 2003-02-04 2005-03-10 Aventis Pharma Deutschland Gmbh N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE10304374A1 (de) * 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN101557810B (zh) * 2006-12-13 2012-11-21 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体(taar)的配体的新的2-咪唑类
EP2173720A2 (en) 2007-07-02 2010-04-14 F. Hoffmann-Roche AG 2-imidazolines having a good affinity to the trace amine associated receptors (taars)
KR101133862B1 (ko) 2007-07-27 2012-04-06 에프. 호프만-라 로슈 아게 Taar 리간드로서의 2-아제티딘메테인아민 및 2-피롤리딘메테인아민
WO2009019149A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
WO2017157873A1 (en) 2016-03-17 2017-09-21 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2988478A (en) * 1958-12-22 1961-06-13 Pfizer & Co C Agricultural compositions and use

Also Published As

Publication number Publication date
DE1695005A1 (de) 1971-02-25
DK121302B (da) 1971-10-04
GR36359B (el) 1969-02-03
CH474522A (de) 1969-06-30
IL27312A (en) 1971-01-28
GB1131191A (en) 1968-10-23
FR6337M (ko) 1968-09-30
NL6701100A (ko) 1967-07-26
NO117129B (ko) 1969-07-07
ES336020A1 (es) 1967-12-16
US3459763A (en) 1969-08-05
FR1508888A (fr) 1968-01-05
AT262997B (de) 1968-07-10
SE339475B (ko) 1971-10-11

Similar Documents

Publication Publication Date Title
FR6337M (ko)
AT281852B (ko)
AU5917865A (ko)
AU424443B2 (ko)
AU428063B2 (ko)
AU414526B2 (ko)
AU421822B2 (ko)
AU417216B2 (ko)
AU415165B1 (ko)
AU433222B2 (ko)
AU1144366A (ko)
AU1111066A (ko)
AU6703465A (ko)
AU5895065A (ko)
AU612166A (ko)
AU92366A (ko)
BE673316A (ko)
BE475118A (ko)
BE654686A (ko)
BE597652A (ko)
BE618801A (ko)
BE447356A (ko)
BE624001A (ko)
BE624223A (ko)
AU415780B2 (ko)